Your browser doesn't support javascript.
loading
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost.
Alayed, Yasir; Loblaw, Andrew; McGuffin, Merrylee; Chung, Hans T; Tseng, Chia-Lin; D'Alimonte, Laura; Cheung, Patrick; Liu, Stanley; Chu, William; Szumacher, Ewa; Helou, Joelle; Ravi, Ananth; Haider, Masoom; Mamedov, Alexandre; Zhang, Liying; Morton, Gerard.
Afiliação
  • Alayed Y; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada; Radiation Oncology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Loblaw A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • McGuffin M; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Chung HT; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Tseng CL; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • D'Alimonte L; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Cheung P; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Liu S; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Szumacher E; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Helou J; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Canada.
  • Ravi A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Haider M; Mount Sinai Hospital, Toronto, Canada.
  • Mamedov A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Zhang L; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Morton G; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada. Electronic address: gerard.morton@sunnybrook.ca.
Radiother Oncol ; 154: 29-35, 2021 01.
Article em En | MEDLINE | ID: mdl-32918971
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article